Page 1217 - TNFlipTest
P. 1217

 Toronto Notes 2019 References Psychiatry PS53
Morishita T, Fayad SM, Higuchi MA, et al, Deep Brain Stimulation for Treatment-resistant Depression: Systematic Review of Clinical Outcomes. J AM Soc, Neurotherapeutics 2014;11(3):475-84. http://doi.org/10.1007/s13311-014-0282-1
MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiat 1999;56:1073-86. Nakamura M, Ogasa M, Guarino J et al. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial. J Clin Psychiatry 2009;70(6):829-36. National Collaborating Centre for Women’s and Children’s Health (UK). Autism: Recognition, Referral and Diagnosis of Children and Young People on the Autism Spectrum. London: RCOG Press; 2011 Sep.
National Institute on Drug Abuse. Research report series: methamphetamine abuse and addiction. Reprinted 2002 Jan. NIH Publication No.: 02-4210. Noble J. Textbook of primary care medicine, 3rd ed. Mosby, 2000. 466-70.
Pagnin D, de Queiroz V, Pini S, et al. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004;20:13-20.
Pail G, Huf W, Pjrek E, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 2011;64(3):152–62.
Patten SB, Wang JL, Williams JV, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry 2006;51:84-90.
Patterson CJ, Gauthier S, Bergman H, et al. Canadian Consensus Conference on Dementia: A Physician’s Guide to Using the Recommendations. CMAJ 1999;160:1738-42. Penttilä M, Jääskeläinen E, Hirvonen N, et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014;205(2):88-94.
Perou R, Bitsko RH, Blumberg SJ. Mental health surveillance among children—United States, 2005-2011. MMWR Suppl. 2013;62(2):1-35.
Pinkofsky HB. Mnemonics for DSM-IV personality disorders. Psychiatr Serv 1997;48(9):1197-8.
Pliszka SR, Greenhill LL, Crismon ML, et al. Textbook of psychiatry. London: Oxford University Press, 1997. 109.
Ravindran AV, Balneaves LG, Faulkner G, et al. CANMAT 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatment. Can J Psychiat 2016;61(9): 576-587.
Reinares M, Rosa AR, Franco C, et al. A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. Intl J Neuropsychopharm 2012;10:1-12. Rosenbaum S, Sherrington C, Tiedemann. A. Exercise augmentation compared with usual care for post-traumatic stress disorder : a randomized controlled trial. Acta Psychiatr Scand 2015;131(5):350-59.
Rush A, Trivedi M, Wisniewski S et al. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. American Journal of Psychiatry. 2006;163(11):1905-1917. doi:10.1176/ajp.2006.163.11.1905.
Russo, EB. Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management 2008;4(1):245-59.
Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 11th ed. Wolters Kluwer, 2014.
Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43.
SchuchFB,Vasconcelos-morenoMP,BorowskyC,etal. Exerciseandseveremajordepression:Effectonsymptomseverityandqualityoflifeatdischargeinaninpatient cohort. J Psychiat Res 2015;61:25-32.
Senger HL. Borderline mnemonic. Am J Psychiatry 1997;154(9):1321.
Stahl SM. Psychopharmacology of antipsychotics. London: Martin Dunitz, 1999.
Stoner SC, Pace HA. Asenapine: a clinical review of a second-generation antipsychotic. Clinical Therapeutics 2012;34:1023-40.
Stroebe M, Schut H, Stroebe W. Health outcomes of bereavement. Lancet 2007;370(9603), 1960-73.
Szewczyk M. Women’s health: depression and related disorders. Primary Care 1997;24:83-101.
Troiden R. The formation of homosexual identities. J Homosexuality 1989;17:43-73.
Warneke L. Breaking the urges of obsessive-compulsive disorder. Can J Diag 1996;13:107-20.
Weller EB, Weller RA, Fristad MA. Bipolar disorder in children: misdiagnosis, underdiagnosis, and future directions. J Am Acad Child Adolescent Psychiat 1995;34:709-14. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-45.
Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders 2013;15:1-44.
Zimmerman M. Interview guide for evaluating DSM-IV psychiatric disorders and the mental status examination. East Greenwich: Psych Products Press, 1994.







































































   1215   1216   1217   1218   1219